| Literature DB >> 32527018 |
Dorothy A Okoth1,2, Joachim J Hug1,2, Ronald Garcia1,2, Cathrin Spröer3, Jörg Overmann2,3, Rolf Müller1,2.
Abstract
Myxobacteria represent an under-investigated source for biologically active natural products featuring intriguing structural moieties with potential applications, e.g., in the pharmaceutical industry. Sorangiadenosine and the here-discovered 2-hydroxysorangiadenosine are myxobacterial sesquiterpene-nucleosides with an unusual structural moiety, a bicyclic eudesmane-type sesquiterpene. As the biosynthesis of these rare terpene-nucleoside hybrid natural products remains elusive, we investigated secondary metabolomes and genomes of several 2-hydroxysorangiadenosine-producing myxobacteria. We report the isolation and full structure elucidation of 2-hydroxysorangiadenosine and its cytotoxic and antibiotic activities and propose a biosynthetic pathway in the myxobacterium Vitiosangium cumulatum MCy10943T.Entities:
Keywords: 2-hydroxysorangiadenosine; antibiotics; biosynthesis; genome-mining; myxobacteria; natural products discovery; secondary metabolites; sorangiadenosine; terpene–nucleoside
Mesh:
Substances:
Year: 2020 PMID: 32527018 PMCID: PMC7321100 DOI: 10.3390/molecules25112676
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Bioactivity-guided metabolome screening of Vitiosangium cumulatum MCy10943T led to the re-discovery of sorangiadenosine (1) and the discovery of 2-hydroxysorangiadenosine (2). The molecular weight, sum formula and MS2 fragmentation pattern of the unknown molecules enabled identification and isolation of 1 and 2. The corresponding biosynthetic gene cluster was identified via in-silico investigation of the MCy10943T genome sequence. Stable isotope-labeled precursor feeding experiments and comparative metabolome investigation of genome-sequenced myxobacterial strains corroborated this analysis. Finally, the outcome of this study led to a proposed biosynthetic route responsible for the biosynthesis of these unique sesquiterpene–adenosine hybrids.
Figure 2(A) Workflow of secondary metabolite screening in MCy10943T, resulting in the independent re-isolation of sorangiadenosine (1) and the discovery of 2-hydroxysorangiadenosine (2). (B) High-performance liquid chromatography–mass spectrometry base peak chromatogram (HPLC-MS BPC) (grey) and extracted ion chromatogram (EIC) of 1 ([M + H]+ 472.2923 m/z, red) and 2 ([M + H]+ 488.2873 m/z, blue) from MCy10943T crude extracts. Fragmentation of sorangiadenosine (C) and 2-hydroxysorangiadenosine (D) in MS2 experiments.
Figure 3Chemical structure and numbering of sorangiadenosine (1) and 2-hydroxysorangiadenosine (2).
Minimum inhibitory concentration (MIC) values of sorangiadenosine and 2-hydroxysorangiadenosine (1 and 2) against common microbial pathogens.
| Microorganism | MIC (µg/mL) of Sorangiadenosine (1) | MIC (µg/mL) of 2-hydroxysorangiadenosine (2) |
|---|---|---|
| 16 | 64 | |
| >128 | >128 | |
| >128 | >128 | |
| >128 | >128 | |
| 32 | 128 | |
| >128 | >128 | |
| >128 | >128 | |
| 128 | >128 | |
| >128 | >128 | |
| >128 | >128 | |
| 128 | >128 |
Half-maximal inhibitory concentrations (IC50 values in µg/mL) of sorangiadenosine, 2-hydroxysorangiadenosine (1 and 2) and doxorubicin (used as cytotoxic positive control) against HCT-116 (human colon carcinoma cell line, DSMZ No. ACC 581) and KB-3-1 (cervix carcinoma cell line, DSMZ No. ACC 158).
| Cancer Cell Line | IC50 (µg/mL) of Sorangiadenosine 1 | IC50 (µg/mL) of 2-hydroxysorangiadenosine 2 | IC50 (µg/mL) of Doxirubicin |
|---|---|---|---|
| HCT-116 | 30.00 | 52.00 | 0.6 |
| KB-3-1 | 39.46 | >111.1 | 0.09 |
Figure 4(A) Proposed biosynthetic route to 1 and 2 based on retrobiosynthetic considerations. (B) Biosynthesis of 1-tuberculosinyladenosine [32].
Biosynthetic gene clusters identified through antiSMASH analysis harboring a terpene cyclase.
| No. | Gene Cluster | Size (bp) | Location | Terpene Cyclase | Associated Biosynthesis 1 |
|---|---|---|---|---|---|
| 1 | Terpene | 27920 | 653776–674051 | 1 × Type I, 2 × Type II | This study |
| 2 | Terpene | 42274 | 1269631–1311904 | 1 × Type I | Geosmin [ |
| 3 | Terpene | 41089 | 3415277–3456365 | 1 × Type I | Genome-Metab |
| 4 | Terpene | 41071 | 3447909–3488979 | 1 × Type I | |
| 5 | Terpene | 40978 | 3603511–3644488 | 1 × Type I | Genome-Metab |
| 6 | Terpene | 41041 | 4852259–4893299 | 1 × Type I | Genome-Metab |
| 7 | Terpene/Type_III_PKS | 69038 | 7156603–7225640 | 1 × Type II | Carotenoid [ |
| 8 | Terpene/TfuA-rel. | 50108 | 8404785–8454892 | 1 × Type I | |
| 9 | Terpene/RiPP | 78053 | 12603875–12681927 | 1 × Type I | Geosmin [ |
1 Genome-Metab.; these gene clusters have been excluded to be responsible for the formation of 1 and 2, due to the genome–metabolome correlation (myxobacterial strains with homologues BGCs featured no detectable production of 1 or 2, see SI).
Figure 5(A) Genetic organization of the candidate biosynthetic gene cluster responsible for the biosynthesis of sorangiadenosine (1) and 2-hydroxysorangiadenosine (2). (B) Proposed biosynthetic route leading to 1 and 2. (C) Catalyzed reactions to increase the supply of adenosine.
Predicted functions of the proteins encoded by the (2-hydroxy)sorangiadenosine biosynthetic gene cluster.
| Gene | Size (aa) | Proposed Function | Closest Homologue | Coverage/Similarity (%) |
|---|---|---|---|---|
|
| 378 | Oxidoreductase | WP_108075222 | 100/95.99 |
|
| 72 | Hypothetical protein | WP_108075223 | 100/93.90 |
|
| 173 | Hypothetical protein | WP_108075224 | 100/82.92 |
|
| 364 | Methionine synthase (MetE) | WP_108075225 | 100/95.87 |
|
| 304 | Hydrolase | WP_108075226 | 100/90.43 |
|
| 284 | Hypothetical protein | WP_108075227 | 95/92.25 |
|
| 457 | Cytochrome P450 enzyme | WP_108069092 | 98/95.67 |
|
| 518 | Eudesmadiene transferase | WP_047856205 | 99/80.31 |
|
| 333 | Terpene cyclase | WP_073564250 | 99.78/79.09 |
|
| 387 | Hypothetical protein | WP_095976240 | 91/56.91 |
|
| 609 | Sensory transducer | WP_146210122 | 92/74.69 |
|
| 509 | Eudesmadiene transferase | WP_108075230 | 100/73.80 |
|
| 1171 | Methionine synthase (MetH) | WP_108075232 | 100/97.61 |
|
| 299 | SAM-dependent methyltransferase | WP_108075233 | 100/97.32 |
|
| 292 | Patatin lipid acyl hydrolases | WP_108075234 | 100/98.97 |
|
| 375 | Dehydrogenase | WP_052519033 | 91/82.11 |
|
| 205 | TetR transcriptional regulator | WP_073564266 | 100/79.62 |
|
| 147 | WP_108075236 | 100/97.26 | |
|
| 302 | Hypothetical protein | WP_108075237 | 100/88.70 |
|
| 449 | Thioredoxin | WP_140874099 | 99/54.81 |
|
| 279 | Hypothetical protein | WP_158079939 | 100/77.34 |
|
| 630 | Phosphotransferase | WP_073564278 | 100/79.83 |